Evaluation of metastatic potential of gastric tumors by staining for proliferating cell nuclear antigen and chromosome 17 numerical aberrations

被引:7
作者
Terada, R
Yasutake, T
Nakamura, S
Hisamatsu, T
Nakagoe, T
Ayabe, H
Tagawa, Y
机构
[1] Nagasaki Univ, Sch Med, Dept Surg 1, Nagasaki 852, Japan
[2] Nagasaki Univ, Sch Allied Med Sci, Dept Occupat Therapy, Nagasaki 852, Japan
关键词
PCNA; chromosome; 17; gastric cancer; lymph node metastasis; fluorescence in situ hybridization (FISH); two-color staining;
D O I
10.1245/aso.2001.8.6.525
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Aberrations in chromosome 17 are important in carcinogenesis. We recently reported that numerical aberrations in chromosome 17 were associated with tumor progression in gastric cancer. The aim of this study was to determine the biological characteristics of gastric tumor cells with chromosome 17 numerical aberrations. Methods: Gastric tumor sections (n = 105) and metastatic lymph nodes (n = 16) were stained simultaneously for PCNA (proliferating cell nuclear antigen) and chromosome 17 centromere, Cancers were classified as follows: Group 1: PCNA(+) and numerical chromosomal aberration(+); Group 2: PCNA(-) and numerical chromosomal aberration(+); Group 3: PCNA(+) and numerical chromosomal aberration(-); and Group 4: PCNA(-) and numerical chromosomal aberration(-). Results: The frequency of Group 1 cells correlated with lymphatic invasion (P <.0001), lymph node metastasis (P <.0001), and venous invasion (P <.01). The frequency of these cells in gastric lesions was lower than in metastatic lymph nodes (P <.01). Logistic regression analysis identified the depth of invasion followed by the frequency of Group I cells were two of the most significant independent factors that could predict lymph node metastasis and lymphatic invasion. Conclusions: The frequency of gastric tumor cells positive for PCNA and chromosome 17 numerical aberrations may be an indicator of the metastatic potential of gastric cancers.
引用
收藏
页码:525 / 532
页数:8
相关论文
共 40 条
[1]  
ASSAD RT, 1980, GASTROENTEROLOGY, V79, P807
[2]  
BAKER SJ, 1990, CANCER RES, V50, P7717
[3]   CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS [J].
BAKER, SJ ;
FEARON, ER ;
NIGRO, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
JESSUP, JM ;
VANTUINEN, P ;
LEDBETTER, DH ;
BARKER, DF ;
NAKAMURA, Y ;
WHITE, R ;
VOGELSTEIN, B .
SCIENCE, 1989, 244 (4901) :217-221
[4]   IDENTIFICATION OF S-PHASE CELLS WITH PC10 ANTIBODY TO PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) BY FLOW CYTOMETRIC ANALYSIS [J].
BEPPU, T ;
ISHIDA, Y ;
ARAI, H ;
WADA, T ;
UESUGI, N ;
SASAKI, K .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1994, 42 (08) :1177-1182
[5]   CYCLIN PCNA IS THE AUXILIARY PROTEIN OF DNA POLYMERASE-DELTA [J].
BRAVO, R ;
FRANK, R ;
BLUNDELL, PA ;
MACDONALDBRAVO, H .
NATURE, 1987, 326 (6112) :515-517
[6]   EXISTENCE OF 2 POPULATIONS OF CYCLIN PROLIFERATING CELL NUCLEAR ANTIGEN DURING THE CELL-CYCLE - ASSOCIATION WITH DNA-REPLICATION SITES [J].
BRAVO, R ;
MACDONALDBRAVO, H .
JOURNAL OF CELL BIOLOGY, 1987, 105 (04) :1549-1554
[7]   TUBULOVILLOUS ADENOMA OF THE COLON WITH HYPERDIPLOIDY, DOUBLE-MINUTE CHROMOSOMES, AND INVERSION OF CHROMOSOME-1 [J].
COUTURIERTURPIN, MH ;
LOUVEL, A ;
COUTURIER, D ;
ESNOUS, C ;
POIRIER, Y ;
NEPVEUX, P .
CANCER GENETICS AND CYTOGENETICS, 1988, 32 (02) :253-262
[8]  
ERNST JMS, 1994, J HSITOCHEM CYTOCHEM, V42, P961
[9]   CYCLIN PCNA IMMUNOSTAINING AS AN ALTERNATIVE TO TRITIATED-THYMIDINE PULSE LABELING FOR MARKING S-PHASE CELLS IN PARAFFIN SECTIONS FROM ANIMAL AND HUMAN-TISSUES [J].
GALAND, P ;
DEGRAEF, C .
CELL AND TISSUE KINETICS, 1989, 22 (05) :383-392
[10]  
Gomyo Y, 1996, INT J CANCER, V66, P594, DOI 10.1002/(SICI)1097-0215(19960529)66:5<594::AID-IJC2>3.0.CO